Tumor Angiogenesis: Initiation and Targeting -Therapeutic Targeting of an FGF-Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas-

참고문헌 (104)

1. "Angiogenesis", 267, pp.10931~4 (1992)
2. "Mechanisms of angiogenesis and arteriogenesis", 6, pp.389~95 (2000)
3. "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis", 86, pp.353~364 (1996)
4. "Role of angiogenesis in tumor growth and metastasis", 29, pp.15~18 (2002)
5. "What is the evidence that tumors are angiogenesis dependent", pp.4~6 (1990)
6. "new concept for therapy of solid tumors", pp.409~16 (1972)
7. "Development and differentiation of endothelium", 67, pp.3~6 (1998)
8. "Molecular regulation of vessel maturation", 9, pp.685~693 (2003)
9. "Openings between defective endothelial cells explain tumor vessel leakiness", 156, pp.1363~1380 (2000)
10. "Regulation of transport pathways in tumor vessels:role of tumor type and microenvironment", 95, pp.4607~4612 (1998)
11. "Vascular permeability factor", vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis, 1999, pp.237, 97~132
12. "Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal", 103, pp.159~165 (1999)
13. "Vasculogenic mimicry and tumor angiogenesis", 156, pp.361~381 (2000)
14. "Mosaic blood vessels in tumors:frequency of cancer cells in contact with flowing blood", 97, pp.14608~14613 (2000)
15. "Fractals and cancer", 60, pp.3683~3688 (2000)
16. "Angiogenesis in cancer and other diseases", 407, pp.249~257 (2000)
17. "Interstitial pH and pO2 gradients in solid tumors in vivo high-resolution measurements reveal a lack of correlation", 3, pp.177~182 (1997)
18. "Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry", 155, pp.739~752 (1999)
19. "Antiangiogenesis drug design:multiple pathways targeting tumor vasculature", 13, pp.849~862 (2006)
20. "The hallmarks of cancer", 100, pp.57~70 (2000)
21. "Fibroblast growth factors their receptors and signaling", 7, pp.165~197 (2000)
22. "Evolution of the Fgf and Fgfr gene families", 20, pp.563~569 (2004)
23. "Fibroblast growth factor", fibroblast growth factor receptor system in angiogenesis, 2005, pp.16, 159~178
24. "Structural basis for fibroblast growth factor receptor activation", 16, pp.107~137 (2005)
25. "Role of fibroblast growth factor-binding protein in the pathogenesis of HIV- associated hemolytic uremic syndrome", 290, pp.105~113 (2006)
26. "Enhancement of fibroblast growth factor activity by an FGF-binding protein", 276, pp.40247~40253 (2001)
27. "Fibroblast growth factor-binding protein is a novel partner for perlecan protein core", 276, pp.10263~10271 (2001)
28. "Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors", 266, pp.16778~85 (1991)
29. "Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors", 269, pp.28243~8 (1994)
30. "A secreted FGF-binding protein can serve as the angiogenic switch in human cancer", 3, pp.1137~1140 (1997)
31. "Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis", 14, pp.2671~2681 (1997)
32. "Identification of the fibroblast growth factor - interacting domain in a secreted FGF-binding protein by phage display", 281, pp.1137~4114 (2006)
33. "Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors", 85, pp.747~755 (2005)
34. "Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT", enhancer-binding protein beta, 2003, pp.63, 1696~1705
35. "Up-regulation of fibroblast growth factor-binding protein by beta-catenin during colon carcinogenesis", 63, pp.8085~8089 (2003)
36. "Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon", 66, pp.1191~8 (2006)
37. "Cancer statistics", 51, pp.15~36 (2001)
38. "Lessons from hereditary colorectal cancer", 87, pp.159~170 (1996)
39. "The genetic basis for human cancer" (2001), McGraw-Hill
40. "The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation:a new facet to Knudson’s ‘two-hit’ hypothesis", 5, pp.1071~1075 (1999)
41. "Inactivation of both APC alleles in human and mouse tumors", 54, pp.5953~8 (1994)
42. "The adenomatous polyposis coli (APC) tumor suppressor", 1332, pp.127~147 (1997)
43. "Association of the APC gene product with beta-catenin", 262, pp.1731~4 (1993)
44. "Association of the APC tumor suppressor protein with catenins", 262, pp.1734~7 (1993)
45. "APC: the plot thickens", 9, pp.595~603 (1999)
46. "Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli", 92, pp.3046~3050 (1995), tumor-suppressor protein
47. "a balance between beta-catenin and APC", 7(genesis), pp.443~446 (1997)
48. "Beta-catenin signaling and cancer", 21, pp.1021~1030 (1999)
49. "Identification of c-MYC as a target of the APC pathway", 281, pp.1509~1512 (1998)
50. "Nuclear endpoint of Wnt signaling neoplastic transformation induced by transactivating lymphoid-enhancing factor 1", 96, pp.139~144 (1999)
51. "Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells", 398, pp.422~426 (1999)
52. "A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse", 247, pp.322~4 (1990)
53. "Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes", 53, pp.549~54 (1988)
54. "Prevalence of ras gene mutations in human colorectal cancers", 327, pp.293~7 (1987)
55. "Detection of high incidence of K-ras oncogenes during human colon tumorigenesis", 327, pp.298~303 (1987)
56. "Ki-ras mutations and prognosis in colorectal cancer", 34, pp.518~521 (1998)
57. "Ras oncogenes in human cancer", pp.4682~9 (1989)
58. "A genetic model for colorectal tumorigenesis", 61, pp.759~67 (1990)
59. "Understanding Ras :‘it ain’t over ‘til it’s over’", 10, pp.147~154 (2000)
60. "The DCC protein and prognosis in colorectal cancer", 335, pp.1727~1732 (1996)
61. "The DCC gene:structural analysis and mutations in colorectal carcinomas", 19, pp.525~31 (1994)
62. "Induction of apoptosis and G2", M cell cycle arrest by DCC, 1999, pp.18, 2747~2754
63. "DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination", 19, pp.546~555 (2000)
64. "Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis", 18, pp.3098~3103 (1999)
65. "Inactivation of both alleles of the DPC4", SMAD4 gene in advanced colorectal cancers identification of seven novel somatic mutations in tumors from Japanese patients, 1999, pp.406, 71~77
66. "Frequent loss of SMAD4", DPC4 protein in colorectal cancers, 2002, pp.51, 56~59
67. "Genetic alterations during colorectal- tumor development", 319, pp.525~32 (1988)
68. "Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas", 244, pp.217~21 (1989)
69. "Disruption of p53 in human cancer cells alters the responses to therapeutic agents", 104, pp.263~269 (1999)
70. "p53 nuclear overexpression:an independent predictor of survival in lymph node--positive colorectal cancer patients", 12, pp.2043~50 (1994)
71. "Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis", 180, pp.364~370 (1996)
72. "Prognostic value of thymidylate synthase and p53 in patients with Dukes' B and C colon cancer", 21, pp.241~250 (2003)
73. "Prognostic value of proliferation and p53 overexpression in patients with resected Dukes' B2 or C colon cancer", 22, pp.1572~1582 (2004)
74. "Cancer statistics", 55, pp.10~30 (2005)
75. "Radiation therapy in pancreatic cancer", 30, pp.230~233 (2000)
76. "Chemotherapy for resectable and advanced pancreatic cancer", 15, pp.1241~1249 (2001)
77. "Pancreatic intraepithelial neoplasia:a new nomenclature and classification system for pancreatic duct lesions", 25, pp.579~586 (2001)
78. "Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms an investigation of tumour cell differentiation and K-ras p53 and c-erbB-2 abnormalities in 26 patients", pp.357~67 (1994)
79. "Genetic progression in the pancreatic ducts", 156, pp.1821~1825 (2000)
80. "Tumor-suppressor genes in pancreatic cancer", 5, pp.383~91 (1998)
81. "Pathways for aberrant angiogenesis in pancreatic cancer", 2(8) (2003)
82. "Increased expression of keratinocyte growth factor in human pancreatic cancer", 215, pp.309~315 (1995)
83. "Expressions of angiogenic factors in pancreatic ductal carcinoma:a correlative study with clinicopathologic parameters and patient survival", 26, pp.344~349 (2003)
84. "Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage", 53, pp.5289~96 (1993)
85. "Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer evidence for autocrine and paracrine actions", 15, pp.1417~1424 (1997)
86. "Adenovirus- mediated transfer of a truncated fibroblast growth factor type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines", 28, pp.25~30 (2004)
87. "IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells", 123, pp.301~313 (2002)
88. "Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis", 17, pp.169~175 (1998)
89. "Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo", 114, pp.798~807 (1998)
90. "Colon cancer angiogenesis and antiangiogenic therapy", 13, pp.631~641 (2004)
91. "what can be expected in clinical practice", 55, pp.67~81 (2005)
92. "Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer", 7, pp.843~848 (1996)
93. "Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer", 78, pp.765~770 (1998)
94. "Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis", 10, pp.722~733 (2003)
95. "Growth factors and oncogenes in gastrointestinal cancers Encyclopedia of molecular cell biology and molecular medicine", pp.1~31 (2005)
96. "Prognostic role of serum vascular endothelial growth factor basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma", 20, pp.184~190 (2002)
97. "Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin", 120, pp.59~65 (2000)
98. "The biological basis for antiangiogenic therapy", 36, pp.1913~1918 (2000)
99. "Tumor angiogenesis: past, present and the near future", 21, pp.505~515 (2000)
100. "Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy", 307, pp.58~62 (2005)
101. "Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer", 23, pp.3697~3705 (2005)
102. "Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer", 350, pp.2335~2342 (2004)
103. "Angiogenesis and cancer", 59, pp.40~50 (2006)
104. "Tumor angiogenesis and therapy", 59, pp.340~343 (2005)

관련 논문AI추천